Prof. de Gramont joined the Scientific Advisory Board of PharmaEngine in January 2006. He has been Professor of Oncology at Saint-Antoine Hospital, Paris, France since 1993 and Chief of Services from 2001 to 2014. Since 2014, he is Professor and Chief of Oncology Services at Institut Hospitalier Franco Britannique, Paris. He has created two cornerstone standard of care regimens (FOLFIRI and FOLFOX) for colorectal cancer and chaired many large international trials for colorectal cancer. He is also the President and Founder of GERCOR and ARCAD Foundation in France. He received his M.D. from Faculty of Medicine Laureate, Paris, France.